ANTIPYRINE AND BENZOCAINE- antipyrine and benzocaine solution
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Topical Decongestant and Analgesic
Antipyrine and Benzocaine Otic Solution is an otic solution containing Antipyrine, Benzocaine, Oxyquinoline Sulfate, and Anhydrous Glycerin for use in the ear. The solution congeals at 0°C (32°F), but returns to normal consistency, unchanged at room temperature.
Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phenyl-3-pyrazolin-5-one. The active ingredient is represented by the structural formula:
C11 H12 N2 O MW=188.22
Antipyrine occurs as colorless crystals or white powder, has a slightly bitter taste and is soluble in water and alcohol.
Benzocaine is a local anesthetic. It is chemically ethyl p-aminobenzoate or Benzoic acid, 4-amino-, ethyl ester. The active ingredient is represented by the structural formula:
C9 H11 NO2 MW=165.19
It occurs as white crystals or white crystalline powder and is slightly soluble in water and soluble in organic solvents.
Actives: Antipyrine 54 mg, Benzocaine 14 mg; Inactives: Glycerine (anhydrous), Oxyquinoline Sulfate.
Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and to alleviate pain and discomfort in acute otitis media.
Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.
Antipyrine and Benzocaine Indications and Usage
- prompt relief of pain and reduction of inflammation in the congestive and serous stages.
- adjuvant therapy during systemic antibiotic administration for resolution of the infection.
Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, especially in children in whom the tube is shorter, wider and more horizontal than in adults.
- facilitates the removal of excessive or impacted cerumen.
The product is contraindicated in any person with hypersensitivity to any of the components or substances related to them. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.
FOR USE IN EARS ONLY-NOT FOR USE IN EYES
Discontinue promptly if sensitization or irritation occurs.
Avoid contaminating the dropper with material from the ear, fingers or other source.
No long term studies have been conducted.
Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to a nursing woman.
Instill Antipyrine and Benzocaine Otic Solution, permitting the solution to run along the wall of the ear canal until it is filled. Avoid touching the ear with dropper.
Then moisten a cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.
Instill Antipyrine and Benzocaine Otic Solution three times daily for two or three days to help detach cerumen from wall of ear canal and facilitate removal.
Antipyrine and Benzocaine Otic Solution is useful for drying out the ear canal or relieving discomfort.
Before and after removal of cerumen, a cotton pledget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following instillation.
Antipyrine and Benzocaine Otic Solution is supplied in plastic bottles containing 15 mL NDC #58980-200-15. A tamper evident seal is on the bottle cap. Do not dispense if the seal is broken.
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Protect from heat and light. Protect from freezing. [See USP Controlled Room Temperature].
Stratus Pharmacueticals Inc
12379 SW 130th Street
Miami, Florida 33186
Customer Service: 800-442-7882
PRINCIPAL DISPLAY PANEL — 15 mL Bottle Label
NOT FOR USE IN EYES
Otic Solution, USP
FOR USE IN THE EARS ONLY
15 mL (1/2 fl. oz.)
| ANTIPYRINE AND BENZOCAINE |
antipyrine and benzocaine solution
|Labeler — Stratus Pharmaceuticals (789001641)|
|Sonar Products Inc||104283945||MANUFACTURE (58980-200)|
Revised: 05/2014 Stratus Pharmaceuticals
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.